Key result
In patients with isolated functional tricuspid regurgitation, a TAPSE/sPAP ratio > 0.4 mm/mmHg was associated with a reduced 2-year risk of all-cause death or heart failure hospitalization (OR 0.41).
Why the study?
Because functional TR symptoms appear late and the optimal timing for valve repair remains challenging, the authors sought to identify right heart remodelling parameters for a simple prognostic model.
Does the combination of TAPSE/sPAP ratio and right atrial volume index predict the risk of death or heart failure hospitalization in patients with isolated functional tricuspid regurgitation?
Cohort (n=160)
Yes
Does the combination of TAPSE/sPAP ratio and right atrial volume index predict the risk of death or heart failure hospitalization in patients with isolated functional tricuspid regurgitation?
Combining the TAPSE/sPAP ratio and right atrial volume index provides a simple and effective prognostic model for predicting clinical events in patients with severe isolated functional tricuspid regurgitation.
Answers are grounded in this paper and cite their sources.
Supports TAPSE/sPAP >0.4 for risk stratification in functional TR; leaves open prospective validation before clinical adoption.
Aims Functional tricuspid regurgitation (TR) is a turning point in cardiac diseases. Symptoms typically appear late. The optimal timing for proposing a valve repair remains a challenge. We sought to analyse the characteristics of right heart remodelling in patients with significant functional TR to identify the parameters that could be used in a simple prognostic model predicting clinical events. Methods and results We designed a prospective observational French multicentre study including 160 patients with significant functional TR (effective regurgitant orifice area > 30 mm2) and left ventricular ejection fraction > 40%. Clinical, echocardiographic, and electrocardiogram data were collected at baseline and at the 1 and 2 year follow-up. The primary outcome was all-cause death or hospitalization for heart failure. At 2 years, 56 patients (35%) achieved the primary outcome. The subset with events showed more advanced right heart remodelling at baseline, but similar TR severity. Right atrial volume index (RAVI) and the tricuspid annular plane systolic excursion to systolic pulmonary arterial pressure (TAPSE/sPAP) ratio, reflecting right ventricular–pulmonary arterial coupling, were 73 mL/m2 and 0.40 vs. 64.7 mL/m2 and 0.50 in the event vs. event-free groups, respectively (both P < 0.05). None among all the clinical and imaging parameters tested had a significant group × time interaction. The multivariable analysis leads to a model including TAPSE/sPAP ratio > 0.4 (odds ratio = 0.41, 95% confidence limit 0.2 to 0.82) and RAVI > 60 mL/m2 (odds ratio = 2.13, 95% confidence limit 0.96 to 4.75), providing a clinically valid prognostic evaluation. Conclusions RAVI and TAPSE/sPAP are relevant for predicting the risk for event at 2 year follow-up in patients with an isolated functional TR.
No takes yet. Share an insight, caveat, or question.
L'official et al. (2023) conducted a cohort in Isolated functional tricuspid regurgitation (n=160). TAPSE/sPAP ratio > 0.4 mm/mmHg vs. TAPSE/sPAP ratio ≤ 0.4 mm/mmHg was evaluated on All-cause death or hospitalization for heart failure (OR 0.41, 95% CI 0.2-0.82, p=<0.05). In patients with isolated functional tricuspid regurgitation, a TAPSE/sPAP ratio > 0.4 mm/mmHg was associated with a reduced 2-year risk of all-cause death or heart failure hospitalization (OR 0.41).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: